Stroke Incidence, Rate of Thrombolytic Therapy, Mortality in Thailand from 2009 to 2021

Somsak Tiamkao; Kamonwon Ienghong; Lap Woon Cheung; Ismet Celebi; Takaaki Suzuki; Korakot Apiratwarakul

doi:10.3889/oamjms.2022.8051

Authors

Somsak Tiamkao Department of Medicine, Division of Neurology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Integrated Epilepsy Research Group, Khon Kaen University, Khon Kaen, Thailand https://orcid.org/0000-0001-5178-478X
Kamonwon Ienghong Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand https://orcid.org/0000-0003-0328-4128
Lap Woon Cheung Department of Accident and Emergency, Princess Margaret Hospital, Kowloon, Hong Kong; Emergency Medicine Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong
Ismet Celebi Department of Paramedic, Gazi University, Ankara, Turkey
Takaaki Suzuki Department of Emergency and Critical Care Medicine, University of Tsukuba Hospital, Tsukuba, Japan
Korakot Apiratwarakul Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand https://orcid.org/0000-0002-1984-0865

DOI:

https://doi.org/10.3889/oamjms.2022.8051

Keywords:

Database, Incidence, Mortality rate, Stroke, Thrombolytic drug

Abstract

BACKGROUND: Thrombolytic treatment is the main treatment of acute ischemic stroke. Thailand started thrombolytic treatment in 2008 only at university hospitals in Bangkok and gradually increased services in large provincial hospitals until widespread in 2014. However, no studies regard the services in stroke management in Thailand.

AIM: This study aims to present data: incidence, rate of thrombolytic treatment, mortality rate of acute stroke in Thailand for 13 years

METHODS: A study from the National Health Security Office's database between 2009 and 2021 was reported using percentage statistics, and the number of patients per 100,000 population.

RESULTS: The overall incidence of acute stroke patients aged 15 years and over was 172.33- 328.00 per 100,000 population. The incidence of acute ischemic stroke patients aged 15 years and over was 90.37-222.73 per 100,000 population. The incidence of non-traumatic intracerebral hemorrhage patients aged 15 years and over was 55.77-87.63 per 100,000 population. Rate of acute ischemic stroke patients who treated with thrombolytic treatment was 0.18-8.04%. Mortality rate of acute stroke patients was 10.24-14.77%. Mortality rate of acute ischemic stroke patients who treated with thrombolytic treatment was 3.97-10.53%.

CONCLUSIONS: Stroke incidence tends to increase over 13 years. Acute ischemic stroke patients receiving thrombolytic treatment tends to increase in number. The mortality rate in patients with acute stroke tends to decline. Especially in patients with acute ischemic stroke, the mortality rate was greatly reduced.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Tiamkao S, Pearkao C, Yubolchit N. Can stroke fast track improve quality of life of patients with acute ischemic stroke? J Med Assoc Thai. 2020;103 Suppl 6:35-41.

Phongphuttha W, Tiamkao S. Outcome of stroke fast-track patients arrival by emergency medical services. J Med Assoc Thai. 2021;104 Suppl 1:S88-93. https://doi.org/10.35755/jmedassocthai.2021.S01.12299 DOI: https://doi.org/10.35755/jmedassocthai.2021.S01.12299

Prabhakaran S, Ruff I, Bernstein RA. Acute stroke intervention: A systematic review. JAMA. 2015;313(14):1451-62. https://doi.org/10.1001/jama.2015.3058 PMid:25871671 DOI: https://doi.org/10.1001/jama.2015.3058

Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA, et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: Data from the global burden of disease 2013 Study. Neuroepidemiology. 2015;45(3):190-202. https://doi.org/10.1159/000441098 PMid:26505983 DOI: https://doi.org/10.1159/000441098

Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: Findings from the global burden of disease study 2010. Lancet. 2014;383(9913):245-54. https://doi.org/10.1016/s0140-6736(13)61953-4 PMid:24449944 DOI: https://doi.org/10.1016/S0140-6736(13)61953-4

Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208-11. https://doi.org/10.1055/s-0038-1649503 PMid:29791947 DOI: https://doi.org/10.1055/s-0038-1649503

Giroud M, Jacquin A, Béjot Y. The worldwide landscape of stroke in the 21st century. Lancet. 2014;383(9913):195-7. https://doi.org/10.1016/s0140-6736(13)62077-2 PMid:24449941 DOI: https://doi.org/10.1016/S0140-6736(13)62077-2

Kim AS, Cahill E, Cheng NT. Global stroke belt geographic variation in stroke burden worldwide. Stroke. 2015;46(12):3564-70. https://doi.org/10.1161/STROKEAHA.115.008226 PMid:26486867 DOI: https://doi.org/10.1161/STROKEAHA.115.008226

Jantasri S, Tiamkao S, Sawanyawisuth K. A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy. Clin Neurol Neurosurg. 2020;198:106206. https://doi.org/10.1016/j.clineuro.2020.106206 PMid:32932029 DOI: https://doi.org/10.1016/j.clineuro.2020.106206

Kijpaisalratana N, Chutinet A, Akarathanawat W, Vongvasinkul P, Suwanwela NC. Outcomes of thrombolytic therapy in acute ischemic stroke: Mothership, drip-and-ship, and ship-and-drip paradigms. BMC Neurol. 2020;20(1):45. https://doi.org/10.1186/s12883-020-1631-9 PMid:32013906 DOI: https://doi.org/10.1186/s12883-020-1631-9

Man S, Xian Y, Holmes DN, Matsouaka RA, Saver JL, Smith EE, Bhatt DL, et al. Association between thrombolytic door-to-needle time and 1-year mortality and readmission in patients with acute ischemic stroke. JAMA. 2020;323(21):2170-84. https://doi.org/10.1001/jama.2020.5697 PMid:32484532 DOI: https://doi.org/10.1001/jama.2020.5697

Sriratanaban J, Ngamkiatpaisarn S, Charoenmukayananta S. Association between hospital accreditation and outcomes: The analysis of inhospital mortality from the national claims data of the universal coverage scheme in Thailand. Qual Manag Health Care. 2020;29(3):150-7. https://doi.org/10.1097/QMH.0000000000000256 PMid:32590490 DOI: https://doi.org/10.1097/QMH.0000000000000256

Schlemm L, Endres M, Werring DJ, Nolte CH. Benefit of intravenous thrombolysis in acute ischemic stroke patients with high cerebral microbleed burden. Stroke. 2020;51(1):232-9. https://doi.org/10.1161/strokeaha.119.027633 PMid:31739772 DOI: https://doi.org/10.1161/STROKEAHA.119.027633

Barlas RS, Clark AB, Bettencourt-Silva JH, Sawanyawisuth K, Kongbunkiat K, Kasemsap N, et al. Pneumonia and risk of serious adverse outcomes in hospitalized strokes in Thailand. J Stroke Cerebrovasc Dis. 2019;28(6):1448-54. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.024 PMid:30956056 DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.024

Reid KA, Barlasm RS, Mamas MA, Clark AB, Kwok CS, Wong CW, et al. Infective endocarditis is associated with worse outcomes in stroke: A Thailand national database study. Int J Clin Pract. 2020;74(11):e13614. https://doi.org/10.1111/ijcp.13614 PMid:32688452 DOI: https://doi.org/10.1111/ijcp.13614

Szlachetka WA, Pana TA, Tiamkao S, Clark AB, Kongbunkiat K, Sawanyawisuth K, et al. Impact of diabetes on complications, long term mortality and recurrence in 608, 890 hospitalised patients with stroke. Glob Heart. 2020;15(1):2. https://doi.org/10.5334/gh.364 PMid:32489775 DOI: https://doi.org/10.5334/gh.364

Pana TA, Wood AD, Perdomo-Lampignano JA, Tiamkao S, Clark AB, Kongbunkiat K, et al. Impact of heart failure on stroke mortality and recurrence. Heart Asia. 2019;11(1):e011139. https://doi.org/10.1136/heartasia-2018-011139 PMid:31244914 DOI: https://doi.org/10.1136/heartasia-2018-011139

Tung IM, Barlas RS, Vart P, Bettencourt-Silva JH, Clark AB, Sawanyawisuth K, et al. Association of chronic kidney disease with outcomes in acute stroke. Acta Neurol Belg. 2021;121(5):1241-6. https://doi.org/10.1007/s13760-020-01416-0 PMid:32661738 DOI: https://doi.org/10.1007/s13760-020-01416-0

Cumming K, Tiamkao S, Kongbunkiat K, Clark AB, Bettencourt- Silva JH, Sawanyawisuth K, et al. Impact of HIV on inpatient mortality and complications in stroke in Thailand: A national database study. Epidemiol Infect. 2017;145(6):1285-91. https:// doi.org/10.1017/S095026881600340X PMid:28137330 DOI: https://doi.org/10.1017/S095026881600340X

Wood AD, Mannu GS, Clark AB, Tiamkao S, Kongbunkiat K, Bettencourt-Silva JH, et al. Rheumatic mitral valve disease is associated with worse outcomes in stroke: A Thailand national database study. Stroke. 2016;47(11):2695-701. https://doi.org/10.1161/strokeaha.116.014512 PMid:27703088 DOI: https://doi.org/10.1161/STROKEAHA.116.014512

di Poggio MB, Finocchi C, Brizzo F, Altomonte F, Bovis F, Mavilio N, et al. Management of acute ischemic stroke, thrombolysis rate, and predictor of clinical outcome. Neurol Sci. 2019;40(2):319-26. https://doi.org/10.1007/s10072-018-3644-3 PMid:30430315 DOI: https://doi.org/10.1007/s10072-018-3644-3

Pinhoa J, Costa AS, Araújo JM, Amorim JM, Ferreir C. Intracerebral hemorrhage outcome: A comprehensive update. J Neurol Sci. 2019;398:54-66. https://doi.org/10.1016/j.jns.2019.01.013 PMid:30682522 DOI: https://doi.org/10.1016/j.jns.2019.01.013

Garg R, Biller J. Recent advances in spontaneous intracerebral hemorrhage. F1000Res. 2019;8:F1000. https://doi.org/10.12688/f1000research.16357.1 PMid:30906532 DOI: https://doi.org/10.12688/f1000research.16357.1